Roadshow
VeriSee DR
VeriSee DR is a diagnostic software for diabetic retinopathy (DR). It uses AI and assists healthcare professionals to analyze retinal images for signs of DR and immediately outputs recommendation on whether the patient should be referred to ophthalmologists. It’s screening accuracy of 93% is comparable to ophthalmologists, and it is approved by Taiwan, Thailand, and Indonesia FDA. VeriSee DR is an effective solution that can shorten the screening process, increase the volume of screenings, improve the accuracy and consistency of the results, reduce costs, and improve patient outcome.
VeriSee DR is an AI-assisted diagnostic software for diabetic retinopathy (DR) that identifies high-risk DR patients. Its core AI model has been trained from images labeled by retina specialists, and the software has been validated in a pivotal clinical trial against a rigorous clinical reference standard. It leverages AI deep learning techniques to produce diagnosis results similar to that of professional ophthalmologists. It has a screening accuracy of 93% on referral recommendations.
The software helps healthcare professionals to analyze retinal images for signs of DR and immediately outputs recommendations on referral to ophthalmologists. Besides, it supports multiple retinal camera brands, such as Topcon, Canon, Crystalvue, Nikon, and MiiS and can be run on a device without network connection.
How It Works
Improving diabetic retinopathy diagnoses and disease tracking
- Established 2018
- Company Acer Medical
- Telephone +886- 2-2696- 0366
Acer Medical was established in 2018 with the mission to improve human health and well-being through artificial intelligence. Leveraging the parent company Acer’s expertise in the information, communication and technology industry, it has focused on the application of artificial intelligence and big data to the field of healthcare. Through interdisciplinary collaborations, Acer Healthcare has established an end-to-end smart healthcare platform the streamlines the development of AI-based medical solutions from product design, technological development, commercialization, to regulatory approval. Acer Healthcare has further obtained GMP and ISO13485 certification for the design and manufacture of medical software. Acer Healthcare is one of the few smart healthcare companies in Taiwan that possess the capabilities to design, develop, commercialize, and successfully implement its AI solutions into medical institutions.